doi: 10.1097/OLQ.0b013e3181f22f56.
Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women
Affiliations
- PMID: 20842073
- PMCID: PMC3786582
- DOI: 10.1097/OLQ.0b013e3181f22f56
Item in Clipboard
Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women
Sex Transm Dis.
2011 Mar.
Abstract
Trichomonas vaginalis (TV) and bacterial vaginosis (BV) were examined among human immunodeficiency virus+ women. The prevalence rates were 28.0% for TV, 51.4% for BV, and 17.5% for TV/BV co-infection. Among human immunodeficiency virus+/TV+ women, the rate of BV was 61.0%. Research is needed to examine how BV affects the clinical course and treatment of T. vaginalis.
Similar articles
-
Co-occurrence of Trichomonas vaginalis and bacterial vaginosis and vaginal shedding of HIV-1 RNA.Sex Transm Dis. 2014 Mar;41(3):173-9. doi: 10.1097/OLQ.0000000000000089. Sex Transm Dis. 2014. PMID: 24521723
-
Genital infections and risk of premature rupture of membranes in Mulago Hospital, Uganda: a case control study.BMC Res Notes. 2015 Oct 16;8:573. doi: 10.1186/s13104-015-1545-6. BMC Res Notes. 2015. PMID: 26475265 Free PMC article.
-
Bacterial vaginosis (BV) and Trichomonas vaginalis (TV) co-infection, and bacterial antibiogram profile of pregnant women studied in Lagos, Nigeria.BMC Womens Health. 2024 Jul 23;24(1):415. doi: 10.1186/s12905-024-03257-y. BMC Womens Health. 2024. PMID: 39039485 Free PMC article.
-
Bacterial Vaginosis and Its Association With Incident Trichomonas vaginalis Infections: A Systematic Review and Meta-Analysis.Sex Transm Dis. 2021 Dec 1;48(12):e192-e201. doi: 10.1097/OLQ.0000000000001537. Sex Transm Dis. 2021. PMID: 34433796 Free PMC article.
-
Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition.Am J Reprod Immunol. 2011 Feb;65(2):89-98. doi: 10.1111/j.1600-0897.2010.00902.x. Am J Reprod Immunol. 2011. PMID: 20678168 Review.
Cited by
-
Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.Lancet Infect Dis. 2018 Nov;18(11):1251-1259. doi: 10.1016/S1473-3099(18)30423-7. Epub 2018 Oct 5. Lancet Infect Dis. 2018. PMID: 30297322 Free PMC article. Clinical Trial.
-
Novel structural features of the immunocompetent ceramide phospho-inositol glycan core from Trichomonas vaginalis.Carbohydr Res. 2016 Jan;419:51-9. doi: 10.1016/j.carres.2015.11.001. Epub 2015 Nov 10. Carbohydr Res. 2016. PMID: 26671321 Free PMC article.
-
Mixed vaginitis-more than coinfection and with therapeutic implications.Curr Infect Dis Rep. 2013 Apr;15(2):104-8. doi: 10.1007/s11908-013-0325-5. Curr Infect Dis Rep. 2013. PMID: 23354954
-
Bacterial vaginosis and the risk of trichomonas vaginalis acquisition among HIV-1-negative women.Sex Transm Dis. 2014 Feb;41(2):123-8. doi: 10.1097/OLQ.0000000000000075. Sex Transm Dis. 2014. PMID: 24413493 Free PMC article. Clinical Trial.
-
Efficacy of single-dose oral secnidazole for the treatment of trichomoniasis in women co-infected with trichomoniasis and bacterial vaginosis: a post hoc subgroup analysis of phase 3 clinical trial data.BMJ Open. 2023 Aug 7;13(8):e072071. doi: 10.1136/bmjopen-2023-072071. BMJ Open. 2023. PMID: 37550019 Free PMC article. Clinical Trial.
References
-
- Kissinger PJ, Dumestre J, Clark RA, et al. Vaginal swabs versus lavage for detection of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women. Sex Transm Dis. 2005;32:227–230. - PubMed
-
- Sorvillo F, Kovacs A, Kerndt P, et al. Risk factors for trichomoniasis among women with human immunodeficiency virus (HIV) infection at a public clinic in Los Angeles County, California: Implications for HIV prevention. Am J Trop Med Hyg. 1998;58:495–500. - PubMed
-
- Seth P, Wingood GM, Diclemente RJ. Exposure to alcohol problems and its association with sexual behaviour and biologically confirmed Trichomonas vaginalis among women living with HIV. Sex Transm Infect. 2008;84:390–392. - PubMed
-
- Magnus M, Clark R, Myers L, et al. Trichomonas vaginalis among HIV-infected women: Are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity? Sex Transm Dis. 2003;30:839–843. - PubMed
-
- Bersoff-Matcha SJ, Horgan MM, Fraser VJ, et al. Sexually transmitted disease acquisition among women infected with human immunodeficiency virus type 1. J Infect Dis. 1998;178:1174–1177. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
